Related Experiment Video
Updated: Jun 22, 2025
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis and anti-proliferative effect of novel 4-Aryl-1, 3-Thiazole-TPP conjugates via mitochondrial uncoupling
Yixin Hu1, Yang Zhang1, Jie Guo2
1Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
With the advent of mitochondrial targeting moiety such as triphenlyphosphonium cation (TPP+), targeting mitochondria in cancer cells has become a promising strategy for combating tumors. Herein, a series of novel 4-aryl-1,3-thiazole derivatives linked to TPP+ moiety were designed and synthesized. The cytotoxicity against a panel of four cancer cell lines was evaluated by CCK-8 assay. Most of these compounds exhibited moderate to good inhibitory activity over HeLa, PC-3 and HCT-15 cells while MCF-7 cells were less sensitive to most compounds. Among them, compound 12a exhibited a significant anti-proliferative activity against HeLa cells, and prompted for further investigation. Specifically, 12a decreased mitochondrial membrane potential and enhanced levels of reactive oxygen species (ROS). The flow cytometry analysis revealed that compound 12a could induce apoptosis and cell cycle arrest at G0/G1 phase in HeLa cells. In addition, mitochondrial bioenergetics assay revealed that 12a displayed mild mitochondrial uncoupling effect. Taken together, these findings suggest the therapeutic potential of compound 12a as an antitumor agent targeting mitochondria.
Insights
Novel thiazole derivatives linked to triphenlyphosphonium cation (TPP+) show promise as mitochondria-targeting antitumor agents. Compound 12a effectively inhibited HeLa cancer cell proliferation by inducing apoptosis and disrupting mitochondrial function.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Mitochondrial Biology
Background:
- Mitochondrial targeting is a promising strategy for cancer therapy.
- Triphenlyphosphonium cation (TPP+) is a key moiety for mitochondrial drug delivery.
Purpose of the Study:
- To design and synthesize novel 4-aryl-1,3-thiazole derivatives linked to TPP+.
- To evaluate the antitumor activity of these compounds against various cancer cell lines.
Main Methods:
- Synthesis of TPP+-conjugated thiazole derivatives.
- Cytotoxicity evaluation using CCK-8 assay.
- Mitochondrial membrane potential and reactive oxygen species (ROS) level assessment.
- Flow cytometry for apoptosis and cell cycle analysis.
- Mitochondrial bioenergetics assays.
Main Results:
- Most synthesized compounds showed moderate to good cytotoxicity against HeLa, PC-3, and HCT-15 cells.
- Compound 12a exhibited significant anti-proliferative activity against HeLa cells.
- Compound 12a decreased mitochondrial membrane potential, increased ROS levels, induced apoptosis, and caused G0/G1 cell cycle arrest.
- Compound 12a demonstrated a mild mitochondrial uncoupling effect.
Conclusions:
- Compound 12a holds therapeutic potential as a mitochondria-targeting antitumor agent.
- The study highlights the efficacy of TPP+-conjugated thiazoles in cancer treatment.
